Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals

American Journal of Respiratory and Critical Care Medicine

Volumn 152, Issue 3, 1995, Pages 1055-1060

  Meyer, Andreas ^b   Buhl, Roland ^b   Kampf, Sabine ^b   Magnussen, Helgo ^a  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUTATHIONE; GLUTATHIONE DISULFIDE; PREDNISONE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GLUTATHIONE METABOLISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG FIBROSIS; LUNG FLUID; LUNG LAVAGE; MALE; PRIORITY JOURNAL; VITAL CAPACITY;

EID: 0029093174     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.152.3.7663783     Document Type: Article

References (35)

1. Meier-Sydow, J., S. M. Weiss, R. Buhl, M. Rust, and G. Raghu. 1994. Idiopathic pulmonary fibrosis: current clinical concepts and challenges in management. Semin. Respir. Crit. Care Med. 15:77-96.
2. Cantin, A. M., S. L. North, G. A. Fells, R. C. Hubbard, and R. G. Crystal. 1987. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J. Clin. Invest. 79:1665-1673.
3. Strausz, J., J. Müller-Quernheim, H. Steppling, and R. Ferlinz. 1990. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 141:124-128.
4. Schraufstätter, I. U., and C. G. Cochrane. 1991. Oxidants: types, sources, and mechanisms of injury. In R. G. Crystal and J. B. West, editors. The Lung: Scientific Foundations. Raven Press, New York. 1803-1810.
5. Warren, J. S., K. J. Johnson, and P. A. Ward. 1991. Consequences of oxidant injury. In R. G. Crystal and J. B. West, editors. The Lung: Scientific Foundations. Raven Press, New York. 1829-1838.
6. Cantin, A. M., S. L. North, R. C. Hubbard, and R. G. Crystal. 1987. Normal alveolar epithelial lining fluid contains high levels of glutathione. J. Appl. Physiol. 63:152-157.
7. Cantin, A. M., R. C. Hubbard, and R. G. Crystal. 1989. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 139:370-372.
8. Cantin, A. M., and R. O. Bégin. 1991. Glutathione and inflammatory disorders of the lung. Lung 169:123-138.
9. Borok, Z., R. Buhl, G. J. Grimes, A. D. Bokser, R. C. Hubbard, K. J. Holroyd, J. H. Roum, D. B. Czerski, A. M. Cantin, and R. G. Crystal. 1991. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 338:215-216.
10. Meyer, A., R. Buhl, and H. Magnussen. 1994. The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur. Respir. J. 7:431-436.
11. Maier, K., L. Leuschel, and U. Costabel. 1991. Increased levels of oxidized methionine residues in BAL fluid proteins from patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 143:271-274.
12. Cantin, A. M., P. Larivée, and R. O. Begin. 1990. Extracellular glutathione suppresses human lung fibroblast proliferation. Am. J. Respir. Cell Mol. Biol. 3:79-85.
13. Buhl, R., C. Vogelmeier, M. Grittenden, R. C. Hubbard, R. F. Hoyt, E. M. Wilson, A. M. Cantin, and R. G. Crystal. 1990. Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proc. Natl. Acad. Sci. USA 87:4603-4607.
14. Holdiness, M. R. 1991. Clinical pharmacokinetics of N-acetylcysteine. Clin. Pharmacokinet. 20:123-134.
15. Burgunder, J. M., A. Varriale, and B. H. Lauterburg. 1989. Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur. J. Clin. Pharmacol. 36:127-131.
16. Bridgeman, M. M. E., M. Marsden, W. MacNee, D. C. Flenley, and A. P. Ryle. 1991. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine. Thorax 46:39-42.
17. de Quay, B., R. Malinverni, and B. H. Lauterburg. 1992. Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 6:815-819.
18. Aebi, S., R. Assereto, and B. H. Lauterburg. 1991. High-dose intravenous glutathione in man: pharmacokinetics and effects on cyst(e)ine in plasma and urine. Eur. J. Clin. Invest. 21:103-110.
19. von Essen, S. G., R. A. Robbins, J. R. Spurzem, A. B. Thompson, S. S. McGranaghan, and S. I. Rennard. 1991. Bronchoscopy with bronchoalveolar lavage causes neutrophil recruitment to the lower respiratory tract. Am. Rev. Respir. Dis. 144:848-854.
20. Rennard, S.I., G. Basset, D. Lecossier, K. M. O'Donnell, P. Pinkston, P. G. Martin, and R. G. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60:532-538.
21. Buhl, R., H. A. Jaffe, K. J. Holroyd, F. B. Wells, A. Mastrangeli, C. Saltini, A. M. Cantin, and R. G. Crystal. 1989. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 11: 1294-1298.
22. Crandall, E. D. 1983. Water and nonelectrolyte transport across alveolar epithelium. Am. Rev. Respir. Dis. 127:S16-S24.
23. Staub, N. C. 1983. Alveolar flooding and clearance. Am. Rev. Respir. Dis. 127:S44-S55.
24. Meister, A. 1991. Glutathione deficiency produced by inhibition of its synthesis, and its reversal: applications in research and therapy. Pharmacol. Ther. 51:155-194.
25. Anderson, M. E., and A. Meister. 1990. Dynamic state of glutathione in blood plasma. J. Biol. Chem. 255:9530-9533.
26. Holroyd, K. J., R. Buhl, Z. Borok, J. H. Roum, A. D. Bokser, G. J. Grimes, D. B. Czerski, A. M. Cantin, and R. G. Crystal. 1993. Correction of the glutathione deficiency in the lower respiratory tract of HIV-seropositive individuals by glutathione aerosol therapy. Thorax 48:985-989.
27. Suter, P. M., G. Domenighetti, M.-D. Schaller, M.-C. Laverrière, R. Ritz, and C. Perret. 1994. N-acetylcysteine enhances recovery from acute lung injury in man. Chest 105:190-194.
28. Pacht, E. R., A. P. Timerman, M. G. Lykens, and A. J. Merola. 1991. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 100:1397-1403.
29. Bunnell, E., and E. R. Pacht. 1993. Oxidized glutathione is increased in the aveolar fluid of patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 148:1174-1178.
30. Smilkstein, M. J., G. L. Knapp, K. W. Kulig, and B. H. Rumack. 1988. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the National Multicenter Study (1976 to 1985). N. Engl. J. Med. 319:1557-1562.
31. Keays, R., P. M. Harrison, J. A. Wendon, A. Forbes, C. Gove, G. J. M. Alexander, and R. Williams. 1991. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trail. B.M.J. 303:1026-1029.
32. Roum, J. H., R. Buhl, N. G. McElvaney, Z. Borok, and R. G. Crystal. 1993. Systemic deficiency of glutathione in cystic fibrosis. J. Appl. Physiol. 75:2419-2424.
33. Li, X. Y., K. Donaldson, I. Rahman, and W. MacNee. 1994. An investigation of the role of glutathione in increased epithelial permeability induced by cigarette smoke in vivo and in vitro. Am. J. Respir. Crit. Care Med. 149:1518-1525.
34. Multicenter Study Group. 1992. Long-term oral acetylcysteine in chronic bronchitis: a double-blind controlled study. Eur. J. Respir. Dis. 61 (Suppl. 111):93-108.
35. DeRemee, R. A. 1994. New approaches to the treatment of pulmonary fibrosis. Eur. Respir. J. 7:427-428.